vx-659
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
4
Phase 4
0
Earliest trial started Nov 1, 2016 (NCT03029455)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vx-659
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03633526 | Phase 3 | Aug 3, 2018 | Vertex |
| NCT03447262 | Phase 3 | Jul 13, 2018 | Vertex |
| NCT03460990 | Phase 3 | May 1, 2018 | Vertex |
| NCT03447249 | Phase 3 | Mar 7, 2018 | Vertex |
| NCT03224351 | Phase 2 | Aug 8, 2017 | Vertex |
| NCT03029455 | Phase 1 | Nov 1, 2016 | Vertex |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vertex | For profit | 6 | 6 | 3 | 2016 |
1 organizations
Page 1 / 1